Verus Capital Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,905
| Closed | -$19.4K | – | 440 |
|
|
2025
Q1 | $19.4K | Sell |
1,905
-8
| -0.4% | -$82 | ﹤0.01% | 407 |
|
|
2024
Q4 | $26.7K | Sell |
1,913
-8
| -0.4% | -$112 | ﹤0.01% | 397 |
|
|
2024
Q3 | $37.5K | Hold |
1,921
| – | – | ﹤0.01% | 389 |
|
|
2024
Q2 | $35.7K | Sell |
1,921
-340
| -15% | -$6.32K | ﹤0.01% | 382 |
|
|
2024
Q1 | $31.7K | Buy |
2,261
+7
| +0.3% | +$98 | ﹤0.01% | 347 |
|
|
2023
Q4 | $19.1K | Sell |
2,254
-333
| -13% | -$2.82K | ﹤0.01% | 321 |
|
|
2023
Q3 | $23.1K | Hold |
2,587
| – | – | ﹤0.01% | 306 |
|
|
2023
Q2 | $22.3K | Sell |
2,587
-394
| -13% | -$3.4K | ﹤0.01% | 294 |
|
|
2023
Q1 | $31.4K | Buy |
2,981
+247
| +9% | +$2.6K | ﹤0.01% | 288 |
|
|
2022
Q4 | $92.7K | Hold |
2,734
| – | – | 0.02% | 259 |
|
|
2022
Q3 | $131K | Buy |
+2,734
| New | +$131K | 0.02% | 256 |
|
|
2022
Q2 | – | Sell |
-3,791
| Closed | -$247K | – | 313 |
|
|
2022
Q1 | $247K | Buy |
+3,791
| New | +$247K | 0.04% | 267 |
|
|
2020
Q1 | $1.55M | Sell |
5,799
-1,324
| -19% | -$355K | 0.49% | 36 |
|
|
2019
Q4 | $2.31M | Buy |
+7,123
| New | +$2.31M | 0.75% | 26 |
|